Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-10-02 01:04:44 - browse：15543

A vial of Tofersen injection on the left of its box — The ALS drug tofersen is marketed as Qalsody in the U.S. Biogen

LONDON — Neurologists and patient advocates are up in arms over a policy decision by a U.K. health agency that they say will imperil access to an ALS treatment that’s available in the U.S. and on its way to approval in the European Union.

The medicine in question, Biogen’s tofersen, is designed to treat a rare genetic form of the neurodegenerative disease, accounting for some 2% of all ALS cases. And the issue is how the U.K.’s cost-effectiveness agency has said it would assess the costs and benefits of the therapy.

The agency, the National Institute for Health and Care Excellence, or NICE, has a special pathway for drugs for very rare diseases, which advocates and doctors argue is the route through which tofersen should be reviewed. But NICE has indicated it would review the drug through its standard process, saying it’s because ALS as a whole does not count as a “very rare” disease. That sets a higher bar to clear.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Study: Black kids more likely to die after surgery than white kids

entertainment

WSS

Insurer loopholes limit power of law against surprise medical bills

Physician executives need more than on

Was Amgen transparent enough on FDA's concern on cancer drug?

When women are denied an abortion, their children fare worse than peers

3 questions for the future of Biden's cancer moonshot

Insurer loopholes limit power of law against surprise medical bills

leisure time

Wikipedia

hotspot

Peter Hotez and the public health issue of online harassment

Hundreds died while taking an arthritis drug, but nobody alerted patients

Guidelines to prevent youth baseball injuries need more muscle

Analysis of telehealth claims data suggest service duplication

Peter Hotez and the public health issue of online harassment

A virus, fished out of a lake, may have saved a man’s life

State Dept. review finds Biden bears some blame for Afghanistan failures

Physician executives need more than on

In age of alternative facts, a scholarly course on calling out crap

Bristol 'take

hotspot

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

Bird flu in dairy cattle: New measures to control spread to humans

Mass General Brigham physicians react to latest merger step

Four alarming medical procedures we’re glad history forgot

Why age limits for politicians are a terrible idea

Why age limits for politicians are a terrible idea

leisure time

knowledge

entertainment

focus